Human cytomegalovirus US28 allows dendritic cell exit from lymph nodes

References

1. Sinclair J, Reeves M. The intimate relationship between human cytomegalovirus and the dendritic cell lineage. Front Microbiol 2014; 5:389 [View Article][PubMed]
   [Google Scholar]
2. Beisser PS, Laurent L, Virelizier JL, Michelson S. Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes. J Virol 2001; 75:5949–5957 [View Article][PubMed]
   [Google Scholar]
3. Krishna BA, Poole EL, Jackson SE, Smit MJ, Wills MR et al. Latency-associated expression of human cytomegalovirus US28 attenuates cell signaling pathways to maintain latent infection. MBio 2017; 8:e01754 [View Article][PubMed]
   [Google Scholar]
4. Vomaske J, Melnychuk RM, Smith PP, Powell J, Hall L et al. Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility. PLoS Pathog 2009; 5:e1000304 [View Article][PubMed]
   [Google Scholar]
5. Farrell HE, Lawler C, Tan CS, Macdonald K, Bruce K et al. Murine cytomegalovirus exploits olfaction to enter new hosts. MBio 2016; 7:e00251-16 [View Article][PubMed]
   [Google Scholar]
6. Farrell HE, Bruce K, Lawler C, Oliveira M, Cardin R et al. Murine cytomegalovirus spreads by dendritic cell recirculation. MBio 2017; 8:e01264 [View Article][PubMed]
   [Google Scholar]
7. Farrell HE, Lawler C, Oliveira MT, Davis-Poynter N, Stevenson PG. Alveolar macrophages are a prominent but nonessential target for murine cytomegalovirus infecting the lungs. J Virol 2015; 90:2756–2766 [View Article][PubMed]
   [Google Scholar]
8. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 2005; 5:617–628 [View Article][PubMed]
   [Google Scholar]
9. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS et al. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 1992; 80:170–178[PubMed]
   [Google Scholar]
10. Mendelson M, Monard S, Sissons P, Sinclair J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 1996; 77:3099–3102 [View Article][PubMed]
    [Google Scholar]
11. Panagou E, Zakout G, Keshani J, Smith C, Irish D et al. Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants. Transpl Infect Dis 2016; 18:405–414 [View Article][PubMed]
    [Google Scholar]
12. Davis-Poynter NJ, Lynch DM, Vally H, Shellam GR, Rawlinson WD et al. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J Virol 1997; 71:1521–1529[PubMed]
    [Google Scholar]
13. Waldhoer M, Kledal TN, Farrell H, Schwartz TW. Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol 2002; 76:8161–8168 [View Article][PubMed]
    [Google Scholar]
14. Farrell HE, Abraham AM, Cardin RD, Sparre-Ulrich AH, Rosenkilde MM et al. Partial functional complementation between human and mouse cytomegalovirus chemokine receptor homologues. J Virol 2011; 85:6091–6095 [View Article][PubMed]
    [Google Scholar]
15. Farrell H, Oliveira M, Macdonald K, Yunis J, Mach M et al. Luciferase-tagged wild-type and tropism-deficient mouse cytomegaloviruses reveal early dynamics of host colonization following peripheral challenge. J Gen Virol 2016; 97:3379–3391 [View Article][PubMed]
    [Google Scholar]
16. Seckert CK, Renzaho A, Reddehase MJ, Grzimek NK. Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection. Med Microbiol Immunol 2008; 197:251–259 [View Article][PubMed]
    [Google Scholar]
17. Case R, Sharp E, Benned-Jensen T, Rosenkilde MM, Davis-Poynter N et al. Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo. J Virol 2008; 82:1884–1898 [View Article][PubMed]
    [Google Scholar]
18. Farrell HE, Abraham AM, Cardin RD, Mølleskov-Jensen AS, Rosenkilde MM et al. Identification of common mechanisms by which human and mouse cytomegalovirus seven-transmembrane receptor homologues contribute to in vivo phenotypes in a mouse model. J Virol 2013; 87:4112–4117 [View Article][PubMed]
    [Google Scholar]
19. Cyster JG, Schwab SR. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol 2012; 30:69–94 [View Article][PubMed]
    [Google Scholar]
20. Boivin G, Quirk MR, Kringstad BA, Germain M, Jordan MC. Early effects of ganciclovir therapy on the quantity of cytomegalovirus DNA in leukocytes of immunocompromised patients. Antimicrob Agents Chemother 1997; 41:860–862[PubMed]
    [Google Scholar]